Reply to the letter to the editor 'Progression-free survival at 24 months (PFS24) and subsequent outcome for patients with diffuse large B-cell lymphoma (DLBCL) in the real-world setting' by van der Galien € et al

M. J. Maurer; T. M. Habermann

doi:10.1093/annonc/mdy492

Reply to the letter to the editor 'Progression-free survival at 24 months (PFS24) and subsequent outcome for patients with diffuse large B-cell lymphoma (DLBCL) in the real-world setting' by van der Galien € et al

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	153
Number of pages	1
Journal	Annals of Oncology
Volume	30
Issue number	1
DOIs	https://doi.org/10.1093/annonc/mdy492
State	Published - Jan 1 2019

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.1093/annonc/mdy492

Cite this

Reply to the letter to the editor 'Progression-free survival at 24 months (PFS24) and subsequent outcome for patients with diffuse large B-cell lymphoma (DLBCL) in the real-world setting' by van der Galien € et al. / Maurer, M. J.; Habermann, T. M.
In: Annals of Oncology, Vol. 30, No. 1, 01.01.2019, p. 153.

Research output: Contribution to journal › Letter › peer-review

@article{d30f70919cb94a848c27a99febdd0a05,

title = "Reply to the letter to the editor 'Progression-free survival at 24 months (PFS24) and subsequent outcome for patients with diffuse large B-cell lymphoma (DLBCL) in the real-world setting' by van der Galien € et al",

author = "Maurer, {M. J.} and Habermann, {T. M.}",

note = "Funding Information: The National Institutes of Health University of Iowa/Mayo Clinic Lymphoma SPORE (CA97274) grant provided support for MJM and TMH.",

year = "2019",

month = jan,

day = "1",

doi = "10.1093/annonc/mdy492",

language = "English (US)",

volume = "30",

pages = "153",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

number = "1",

}

TY - JOUR

T1 - Reply to the letter to the editor 'Progression-free survival at 24 months (PFS24) and subsequent outcome for patients with diffuse large B-cell lymphoma (DLBCL) in the real-world setting' by van der Galien € et al

AU - Maurer, M. J.

AU - Habermann, T. M.

N1 - Funding Information: The National Institutes of Health University of Iowa/Mayo Clinic Lymphoma SPORE (CA97274) grant provided support for MJM and TMH.

PY - 2019/1/1

Y1 - 2019/1/1

UR - http://www.scopus.com/inward/record.url?scp=85060170343&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060170343&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdy492

DO - 10.1093/annonc/mdy492

M3 - Letter

C2 - 30395156

AN - SCOPUS:85060170343

SN - 0923-7534

VL - 30

SP - 153

JO - Annals of Oncology

JF - Annals of Oncology

IS - 1

ER -

Reply to the letter to the editor 'Progression-free survival at 24 months (PFS24) and subsequent outcome for patients with diffuse large B-cell lymphoma (DLBCL) in the real-world setting' by van der Galien € et al

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this